




Coronary Artery Disease – In 61 eligible trials involving 25 388 patients with non-acute coronary artery disease there was no benefit over drug-medical therapy with percutaneous transluminal balloon coronary angioplasty (PTCA), bare-metal stents (BMS), and drug-eluting stents (DES). Optimizing medical therapy first before these procedures is recommended in non-acute coronary disease….[More]